Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain - sprookjes - yvandenbroek - TriplyDB

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

http://www.wikidata.org/entity/Q27003253

about

Beyond Diabetes: Does Obesity-Induced Oxidative Stress Drive the Aging Process?Therapies for Prevention and Treatment of Alzheimer's Disease Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease Alzheimer's Disease: Mechanism and Approach to Cell Therapy Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance Amylin at the interface between metabolic and neurodegenerative disorders Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease Aberrant insulin signaling in Alzheimer's disease: current knowledge Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Diabetes mellitus and cognitive impairments The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study.Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.Zinc and Oxidative Stress: Current Mechanisms The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.Impact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intake Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders.Effects of exercise on brain functions in diabetic animal models.In vitro anti-HIV and antioxidant activity of Hoodia gordonii (Apocynaceae), a commercial plant product.Effects of rhein lysinate on D-galactose-induced aging mice.A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients with Type 2 Diabetes Using Tract-Based Spatial Statistics.DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells The Association Between Diabetes and Dementia Among Elderly Individuals: A Nationwide Inpatient Sample Analysis.Biotic/Abiotic Stress-Driven Alzheimer's Disease.Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.Controlled curcumin release via conjugation into PBAE nanogels enhances mitochondrial protection against oxidative stress.Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice.Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation.Chronic Administration of Rosa canina Hydro-Alcoholic Extract Attenuates Depressive-Like Behavior and Recognition Memory Impairment in Diabetic Mice: A Possible Role of Oxidative Stress.Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease.Mitochondrial GSH Systems in CA1 Pyramidal Cells and Astrocytes React Differently during Oxygen-Glucose Deprivation and Reperfusion.Oxidative stress and the amyloid beta peptide in Alzheimer's disease.Metabolic clues to salubrious longevity in the brain of the longest-lived rodent: the naked mole-rat.Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.

P2860

Q26738696-4AB47DE0-04E8-494C-8D20-6440D12125B6 Q26740007-FA93CF99-5027-4CBF-9112-6BEC6BAE08DC Q26773657-8015D2BF-E635-4A61-BAB0-59F9247F6CEA Q26778149-C6FE69FC-A755-47AB-A5CB-5872CBFF8A78 Q26800081-1A41AF67-6C85-44ED-99EF-B29B596435B1 Q26800114-0CA91E22-D469-4FBC-A7C2-4EED3DEC255E Q27003342-ADAD9FED-02F3-4252-9F47-616626D063CE Q27024122-3FAC5219-244A-4F19-BD72-016E33DDCB38 Q27024222-8C439FD7-0756-449A-B534-31DEC62DFCE5 Q27338799-A3B91267-FD6A-49B9-979B-A57577785132 Q28079459-9BC041DF-0F06-4A13-9E69-E38B22F7C6ED Q28608506-2C4921A5-572F-4A37-84AB-B351B5826EFB Q33614523-D873DB88-B8E0-49EC-92EE-96389AC62627 Q33624944-24BB8D83-0559-4A30-884E-55B57976A524 Q33800802-3E516CB5-2B18-4D0F-9DC8-DE31EF9FC677 Q33845013-9279B795-14C1-4A1F-A48D-948956DFC828 Q33851630-74BCE05B-AA8C-4EEC-A723-8F1A24ED43CA Q34833657-1500C3B0-9133-4174-A81F-F94BBCBE80A6 Q35114807-81BD4FBD-C2F6-4240-A156-6C56E94F5E7D Q35143091-F0CAD79E-FE20-48BE-BBFF-656CB8481DF2 Q35613905-DA53CC99-F1B2-4787-B100-F9DFC67B84B9 Q36173448-9E948407-CC95-4733-9481-B2DE7C7176D4 Q36502521-F376CBBF-730E-43C6-8FEA-7719C25601A4 Q37172347-4C941141-8CB1-49CC-8832-B15D4962BCAC Q37275631-C3C33D43-4E72-4131-97C4-D50D55C87C6D Q37404548-31DA56EA-0BE3-4DD3-8AD3-D4F1B619A321 Q37430445-5FD1F8A0-93F8-4997-A7A4-2CB3F3CD133A Q38673914-9336A1ED-6EDB-4E2A-97C3-D110924C21A4 Q38974881-F4A419D3-B52B-4F65-A1B5-BB657AAC76E3 Q39276899-65BEC70D-A46F-4AFF-864E-63CB2EE9D9FA Q39332179-17E16229-7650-4F2E-8E71-D6D67001F5FF Q41110161-713C4AB5-E571-43BA-B7D8-E249E57CECAB Q41279397-C25EA130-D5FC-4C92-AE12-8EA55AC97584 Q41714460-2AD3A89B-F3FD-4943-AFD2-4F42A1F83CDA Q42756158-DDD87D78-5691-44D3-AE2A-147B3B0A4EC2 Q45967931-A64E8931-A31C-4E85-A166-96CF9425C04D Q46254796-D1C0847C-855B-4434-8A0E-C6F89FB90902 Q46272723-EC6F0F82-AC0C-478B-ADF3-1A38EE0D4DC1 Q46733752-00EB6952-1540-46D7-A214-A0F1CCCE656F Q46778500-FD415F80-8E77-4652-B840-A7E7798928EB

P2860

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

http://www.wikidata.org/entity/Q27003253

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@ast

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@en

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@nl

type

label

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@ast

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@en

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@nl

prefLabel

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@ast

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@en

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@nl

P1433

Q27003253-16BD7785-1A6F-4DDF-B005-9192ED9CCBAD

P1476

Q27003253-FFCA3B8D-1C72-4962-A679-9F6226B25015

P2093

Q27003253-9A3B0ECA-0650-4F36-AF04-BBEB9CD5ECB1

P2860

Q27003253-00B56C20-4050-4CE9-8F16-6EA6EB5FEFFB

Q27003253-00D3AC6B-CD84-40C0-A3F3-1AE12A727E89

Q27003253-016CF0F5-457D-4BF9-B06E-C5576E770687

Q27003253-05E56502-BAB7-4270-9108-1604CB386493

Q27003253-07421E92-5095-4B71-ADD6-EAC8C4AE32F3

Q27003253-0A94FB69-98D9-4B27-A397-E216CE5C4890

Q27003253-0B35A25D-E3B3-4177-BBB9-6DEEF1A58FC2

Q27003253-0D868C56-DB37-4D63-A585-C093A513B1F2

Q27003253-0F3F7E1D-971F-4788-BE29-04A92F0F385B

Q27003253-10375B51-76C2-4259-9984-0DCE6CFB5F7F

P304

Q27003253-7995E93F-5804-4CC0-9FD6-820BF0A20B90

P31

Q27003253-C945C76D-9202-43B9-BF24-35F7FBE9BA50

P3181

Q27003253-4D0E33E3-A0E5-4693-BD2A-2F83F40BC393

P356

Q27003253-1998413B-7331-4C2D-B717-4167664CCF01

P407

Q27003253-E03BB8E5-0868-4BBA-ACDB-94FBC31692D7

P433

Q27003253-56691C31-2B43-4D43-A8C9-4F8366CFD367

P478

Q27003253-8EE1A678-6A9D-451B-AE8C-ADB5D5621E7D

P50

Q27003253-42629210-DDD6-4FA2-B996-808DB29E7B3A

Q27003253-6273AD09-71B4-4719-A7DB-096B5CF7D11F

P577

Q27003253-91693D36-C2F1-414F-85B0-199455F866B4

P5875

Q27003253-2AC9362C-60FB-4300-87B8-D058634F3F0B

P698

Q27003253-1B1906FD-82AC-44BA-B32B-B6B13FFF99A9

P921

Q27003253-373A4126-3DCD-4D3E-92C1-4664FA8EBCF9

Q27003253-6C02E7A2-EC8E-4062-A17E-846DAE2BC5BB

Q27003253-B9DD8026-864E-4971-A47D-2045BD0D7414

P932

Q27003253-5789AD4A-08AE-4FF8-A654-9A1076F04A1F

P3181

P356

J.BBADIS.2014.06.010

P1433

Biochimica et Biophysica Acta

P1476

Elevated risk of type 2 diabet ...... for oxidative stress in brain

@en

P2093

D Allan Butterfield

http://www.w3.org/2001/XMLSchema#string

P2860

Free radicals and antioxidants in normal physiological functions and human disease

The antidiabetic gutsy role of metformin uncovered?

Alzheimer's Disease

Molecular mechanism of action of metformin: old or new insights?

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

Free radicals in the physiological control of cell function

P304

1693-1706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2831590

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BBADIS.2014.06.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

1842

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Di Domenico

P577

2014-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263289237

http://www.w3.org/2001/XMLSchema#string

P698

24949886

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

type-2 diabetes

P932

4125611

http://www.w3.org/2001/XMLSchema#string